Study identifies large number of undiagnosed patients likely infected with hepatitis C in Sweden

NewsGuard 100/100 Score

Using a large transfusion database, with data going back to the 1960s, researchers at Karolinska Institutet have been able to identify 44 donors and 1,180 transfused patients likely to be infected with hepatitis C, who are still alive and who remain undiagnosed.

Many patients who received blood transfusions between the 1960s and 80s were infected with the hepatitis C virus. Thankfully, after blood donor testing was implemented around the year 1990, infection risks all but disappeared, but many previously infected patients have never been traced.

The hepatitis C virus, which causes inflammation of the liver, sometimes leading to liver failure or cancer. Large numbers of patients were infected with hepatitis C through blood transfusions. Thankfully, these risks were all but eliminated when testing of blood donors was implemented around year 1990. Although many previously infected patients have been identified, large numbers of patients are likely unaware that they are infected.

In this study, researchers at Karolinska Institutet and the Swedish Public Health Agency, used data from a large Swedish database of blood donors and transfused patients, with data going back 1960's. Using a combination of statistical techniques, they identified 1,180 transfused patients and 44 blood donors who are likely to be infected with the hepatitis C virus and who remain alive and undiagnosed. Importantly, the researchers found no evidence that the hepatitis C virus was transmitted after 1991.

The findings are mostly expected, but we were a little bit surprised by the large number of patients."

Gustaf Edgren, Senior Researcher, Department of Medicine, Solna, Karolinska Institutet

The researchers now plan to contact the identified patients and donors and offer them testing and, if they are found to be infected, to ensure that they are offered treatment.

Source:
Journal reference:

Dahl, V., et al. (2020) Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012. Eurosurveillance. doi.org/10.2807/1560-7917.ES.2020.25.29.1900537.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adeno-associated virus: The gene therapy revolution faces manufacturing and safety hurdles